NCT01689766View on ClinicalTrials.gov

Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

November 30, 2007

Conditions
Metastatic Renal Cell Carcinoma
Interventions
DRUG

Technetium Tc 99m EC20

Trial Locations (2)

55905

Mayo Clinic, Rochester

77030

Baylor College of Medicine, Houston

Sponsors

Lead Sponsor

Endocyte
All Listed Sponsors
lead

Endocyte

INDUSTRY

NCT01689766 - Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter